Worldquant Millennium Advisors LLC Acquires 171,964 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Worldquant Millennium Advisors LLC increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 223.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 248,818 shares of the medical device company's stock after acquiring an additional 171,964 shares during the period. Worldquant Millennium Advisors LLC owned about 0.12% of Cooper Companies worth $22,874,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of COO. Covestor Ltd raised its stake in shares of Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after acquiring an additional 120 shares in the last quarter. Shell Asset Management Co. raised its stake in shares of Cooper Companies by 15.5% in the 4th quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock valued at $87,000 after acquiring an additional 127 shares in the last quarter. Torray Investment Partners LLC raised its stake in shares of Cooper Companies by 0.8% in the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock valued at $1,488,000 after acquiring an additional 132 shares in the last quarter. Mather Group LLC. raised its stake in shares of Cooper Companies by 7.4% in the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock valued at $177,000 after acquiring an additional 133 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB raised its stake in shares of Cooper Companies by 15.6% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock valued at $93,000 after acquiring an additional 136 shares in the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

COO stock traded down $0.47 on Friday, reaching $78.83. 1,548,951 shares of the company were exchanged, compared to its average volume of 1,493,548. The Cooper Companies, Inc. has a 12 month low of $69.81 and a 12 month high of $112.38. The stock's fifty day moving average price is $80.25 and its 200 day moving average price is $89.24. The firm has a market capitalization of $15.76 billion, a PE ratio of 40.43, a PEG ratio of 2.25 and a beta of 1.08. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. On average, research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on COO. Wall Street Zen raised Cooper Companies from a "hold" rating to a "buy" rating in a research note on Wednesday. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a report on Thursday. Citigroup decreased their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a report on Friday, March 7th. Stifel Nicolaus decreased their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Finally, Robert W. Baird decreased their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.